User:Danski14/prep6

Bartley J. Madden (1943 - )

Life and education
Madden was born on November 3, 1943 in New York City. He studied engineering at the California Polytechnic State University, San Luis Obispo and was a member of Cal Poly’s 1961 championship boxing team. From 1962-1965 he completed his degree in mechanical engineering at the University of Southern California. After working as an engineer and serving in the Army at Dugway Proving Grounds as a test engineer, he completed his MBA at the University of California, Berkeley in 1969.

Career
In 1969, Madden founded Callard Madden & Associates, a firm that specialized in advanced research connecting financial performance to stock prices. His early work was instrumental in the development of the cash-flow return on investment (CFROI) valuation model that is now widely used by money management organizations. In 1984, he transitioned to money management as a Senior Vice President at Harbor Capital Advisors. In 1993, he joined HOLT Value Associates to continue the research and development of the CFROI valuation model and related global database. Credit Suisse acquired HOLT in 2002. The following year Madden retired as a managing director of Credit Suisse and began writing journal articles and books focused on his three main areas of interest: the management and market valuation of firms, systems thinking, and knowledge building.

Madden has written extensively about the Free To Choose Medicine proposal to enable patients, advised by their doctors, to make informed decisions about the use of not-yet-approved drugs that have successfully passed initial safety and efficacy trials. An early version of this proposal was translated into Japanese and played a significant role in Japan’s 2014 implementation of conditional approval for early access to regenerative medicine treatments.

Madden and his sons, Gregory and Jeffrey, run the Bartley J. Madden Foundation that promotes free-market capitalism in order to maximize innovation and opportunity and achieve widespread prosperity. “Science on FDA Liberalization: A Response to the Status Quo Process for Medical Treatments.” 2020. Econ Journal Watch 17(1): 90-96. This article is a reply to a Science article critical of Free To Choose Medicine https://econjwatch.org/articles/science-on-fda-liberalization-a-response-to-the-status-quo-process-for-medical-treatments

PBS TV hosted a two-part interview with Madden and James Doti, President of Chapman University, focused on Free To Choose Medicine. Part 1 https://www.youtube.com/watch?v=fq650Mm_q6E Part 2 https://www.youtube.com/watch?v=e1L_URVwHL0